LEADER 01529oam  2200493zu 450 
001 9910693524103321
005 20210807004528.0
035   $a(CKB)3450000000002030
035   $a(SSID)ssj0000578174
035   $a(PQKBManifestationID)12195820
035   $a(PQKBTitleCode)TC0000578174
035   $a(PQKBWorkID)10577297
035   $a(PQKB)22160637
035   $a(OCoLC)46636714
035 9 $aocm46636714
035   $a(OCoLC)993450000000002030
035   $a(EXLCZ)993450000000002030
100   $a20160829d2001      uy              
101 0 $aeng
135   $aurun||||||
181   $ctxt
182   $cc
183   $acr
200 10$aManagement of acute otitis media
210 31$a[Place of publication not identified]$cAHRQ$d2001
225 1 $aEvidence report/technology assessment. Summary ;$vno. 15
225 1 $aAHRQ publication ;$vno. 00-E 008
300   $aBibliographic Level Mode of Issuance: Monograph
606   $aOtitis Media$xdrug therapy
606   $aAmoxicillin$xtherapeutic use
606   $aChild
606   $aEvaluation Studies as Topic
615 12$aOtitis Media$xdrug therapy.
615 22$aAmoxicillin$xtherapeutic use.
615 22$aChild,
615 22$aEvaluation Studies as Topic.
700   $aMarcy$b Michael$01351401
702   $aTakata$b Glenn
712 02$aUnited States Agency for Healthcare Research and Quality
801  0$bPQKB
906   $aBOOK
912   $a9910693524103321
996   $aManagement of acute otitis media$93103855
997   $aUNINA